A Neurolucida and Stereo Investigator Imaging System with MicroLucida
采用 MicroLucida 的 Neurolucida 和 Stereo Investigator 成像系统
基本信息
- 批准号:8247678
- 负责人:
- 金额:$ 31.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-15 至 2013-05-14
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAstrocytesBiologicalBrainCell CountCell TransplantsCicatrixCognitiveDimensionsDiseaseEngraftmentEtiologyFundingGliosisHuntington DiseaseImageImaging TechniquesImpairmentInjuryInstitutesLabelLesionLightingMeasurementMemory impairmentMethodsMotorMultiple SclerosisNervous system structureNeurodegenerative DisordersNeuronsResearch PersonnelScienceSenile PlaquesSpinal cord injuryStructureSynapsesSystemThree-Dimensional ImageTimeTissuesTraumatic Brain InjuryVentricularbasebrain irradiation injurydevelopmental diseaseimmunocytochemistrymembernervous system disorderneurogenesisneuroinflammationneuron lossrelating to nervous systemstatisticstissue processing
项目摘要
DESCRIPTION (provided by applicant): Neurological disorders such as Alzheimer's and Huntington's disease, spinal cord injury, traumatic brain injury, multiple sclerosis, radiation injury, and brain developmental disorders are characterized by profound neuronal and glial injury, leading to significant impairments in cognitive and/or motor functions. Although the etiology of these disorders vary, the signature and defining pathological features for many of these conditions is the loss of neurons and synapses, loss of neuronal connectivity, tissue volume loss and expansion of the ventricular spaces, dysregulated neurogenesis, and rampant neuroinflammation, gliosis, and scarring. The investigators listed on this proposal are all members of the Institute for Memory Impairments and Neurological disorders at UC Irvine (UCI MIND), and are seeking funds to acquire a multichannel fluorescent structured illumination stereological imaging system to quantify tissue changes with unbiased methods. Neuropathological studies are severely limited by attempts to study three-dimensional interactions by observations made in two dimensions. Stereology, however, is a science that overcomes these limitations by furnishing three- dimensional interpretations of planar sections of biological tissues, as it is based on merging of the principles of geometry and statistics. Consequently, stereological studies of the nervous system provide a means to obtain more precise quantitative measurements of cell number and neural processes and tissue volume. In addition, for studies on neurodegenerative disorders, it is possible to determine the quantitative relationship between the accumulation of brain lesions such as amyloid plaques and cell number, for example. Standard brightfield stereology allows one to accurately quantify one immunolabel at a time in tisue sections. Double and/or triple labeling immunocytochemistry typically require fluorescent labeling and more specialized imaging techniques. An Apotome structured illumination system allows confocal-like 3D images to be acquired for both real-time and off-line analysis of multiple labels. Such a system would allow investigators to quantify two or three parameters simultaneously (e.g. total number of GFP-expressing transplanted cells, and a second or third fate marker to obtain total engraftment numbers and percentage of neural, astroglia and oligodendroglial fate in the same tissue sections).
描述(申请人提供):阿尔茨海默氏症和亨廷顿病、脊髓损伤、创伤性脑损伤、多发性硬化症、辐射损伤和脑发育障碍等神经疾病的特征是严重的神经元和神经胶质损伤,导致认知和/或运动功能严重受损。虽然这些疾病的病因各不相同,但许多疾病的标志性和决定性的病理特征是神经元和突触的丧失,神经元连通性的丧失,组织体积的丧失和脑室空间的扩张,神经发生的失调,以及猖獗的神经炎症、胶质增生和瘢痕形成。该提案中列出的研究人员都是加州大学欧文分校记忆损伤和神经疾病研究所(UCI Mind)的成员,他们正在寻求资金,以获得一种多通道荧光结构照明立体成像系统,以无偏见的方法量化组织变化。神经病理学研究严重受限于试图通过二维观察来研究三维相互作用。然而,体视学是一门通过提供生物组织平面切片的三维解释来克服这些限制的科学,因为它是基于几何学和统计学原理的融合。因此,神经系统的体视学研究提供了一种对细胞数量、神经突起和组织体积进行更精确的定量测量的方法。此外,对于神经退行性疾病的研究,例如,有可能确定大脑损伤(如淀粉样斑块)的积累和细胞数量之间的定量关系。标准的Brightfield体视学使人们可以在组织切片中一次准确地定量一个免疫标记。双重和/或三重标记免疫细胞化学通常需要荧光标记和更专门的成像技术。Apotome结构化照明系统允许获取共焦样3D图像以用于多个标签的实时和离线分析。这样的系统将允许研究人员同时量化两到三个参数(例如,表达GFP的移植细胞总数,以及第二个或第三个命运标记,以获得同一组织切片中神经、星形胶质细胞和少突胶质细胞命运的总植入数量和百分比)。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
- DOI:10.1002/glia.23522
- 发表时间:2018-12
- 期刊:
- 影响因子:6.2
- 作者:Lim SL;Tran DN;Zumkehr J;Chen C;Ghiaar S;Kieu Z;Villanueva E;Gallup V;Rodriguez-Ortiz CJ;Kitazawa M
- 通讯作者:Kitazawa M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK M LAFERLA其他文献
FRANK M LAFERLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK M LAFERLA', 18)}}的其他基金
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10463741 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10636861 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10280235 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10582616 - 财政年份:2020
- 资助金额:
$ 31.08万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10774385 - 财政年份:2020
- 资助金额:
$ 31.08万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10747262 - 财政年份:2020
- 资助金额:
$ 31.08万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
9922099 - 财政年份:2020
- 资助金额:
$ 31.08万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 31.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 31.08万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 31.08万 - 项目类别: